Torti FM - Search Results

1

Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583).

Small EJ, Halabi S, Dawson NA, Stadler WM, Rini BI, Picus J, Gable P, Torti FM, Kaplan E, Vogelzang NJ. Small EJ, et al. Among authors: torti fm. J Clin Oncol. 2004 Mar 15;22(6):1025-33. doi: 10.1200/JCO.2004.06.037. J Clin Oncol. 2004. PMID: 15020604 Clinical Trial.

2

A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.

Stadler WM, Desai AA, Quinn DI, Bukowski R, Poiesz B, Kardinal CG, Lewis N, Makalinao A, Murray P, Torti FM. Stadler WM, et al. Among authors: torti fm. Cancer Chemother Pharmacol. 2008 Apr;61(4):689-94. doi: 10.1007/s00280-007-0524-6. Epub 2007 Jun 14. Cancer Chemother Pharmacol. 2008. PMID: 17569043 Clinical Trial.

3

Recent advances in the treatment of prostate cancer.

Kuyu H, Lee WR, Bare R, Hall MC, Torti FM. Kuyu H, et al. Among authors: torti fm. Ann Oncol. 1999 Aug;10(8):891-8. doi: 10.1023/a:1008385607847. Ann Oncol. 1999. PMID: 10509148 Free article. Review.

4

Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer.

Schwartz GG, Hall MC, Stindt D, Patton S, Lovato J, Torti FM. Schwartz GG, et al. Among authors: torti fm. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8680-5. doi: 10.1158/1078-0432.CCR-05-1237. Clin Cancer Res. 2005. PMID: 16361554 Clinical Trial.

5

Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy.

Clark PE, Hall MC, Borden LS Jr, Miller AA, Hu JJ, Lee WR, Stindt D, D'Agostino R Jr, Lovato J, Harmon M, Torti FM. Clark PE, et al. Among authors: torti fm. Urology. 2006 Jun;67(6):1257-61. doi: 10.1016/j.urology.2005.12.035. Urology. 2006. PMID: 16765186 Clinical Trial.

6

Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study.

Torti FM, Shortliffe LD, Williams RD, Pitts WC, Kempson RL, Ross JC, Palmer J, Meyers F, Ferrari M, Hannigan J, et al. Torti FM, et al. J Clin Oncol. 1988 Mar;6(3):476-83. doi: 10.1200/JCO.1988.6.3.476. J Clin Oncol. 1988. PMID: 3280742 Clinical Trial.

7

Vinorelbine, doxorubicin, and prednisone in androgen-independent prostate cancer.

Borden LS Jr, Clark PE, Lovato J, Hall MC, Stindt D, Harmon M, M Mohler R, Torti FM. Borden LS Jr, et al. Among authors: torti fm. Cancer. 2006 Sep 1;107(5):1093-100. doi: 10.1002/cncr.22078. Cancer. 2006. PMID: 16888761 Free article. Clinical Trial.

8

Bone metastases in prostate cancer: a targeted approach.

Storey JA, Torti FM. Storey JA, et al. Among authors: torti fm. Curr Opin Oncol. 2007 May;19(3):254-8. doi: 10.1097/CCO.0b013e32805e8787. Curr Opin Oncol. 2007. PMID: 17414645 Review.

9

Carcinoma of the prostate: pathology, staging, and treatment.

Freiha FS, Bagshaw MA, Torti FM. Freiha FS, et al. Among authors: torti fm. Curr Probl Cancer. 1988 Nov-Dec;12(6):329-411. doi: 10.1016/s0147-0272(88)80003-5. Curr Probl Cancer. 1988. PMID: 3069334 Review.

10

Weekly doxorubicin in endocrine-refractory carcinoma of the prostate.

Torti FM, Aston D, Lum BL, Kohler M, Williams R, Spaulding JT, Shortliffe L, Freiha FS. Torti FM, et al. J Clin Oncol. 1983 Aug;1(8):477-82. doi: 10.1200/JCO.1983.1.8.477. J Clin Oncol. 1983. PMID: 6668511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters